Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 96, Issue , 2015, Pages 162-172

  Anwar, Mohammed ^a   Ahmad, Iqbal ^a   Warsi, Musarrat H ^a   Mohapatra, Sharmistha ^a   Ahmad, Niyaz ^a   Akhter, Sohail ^b   Ali, Asgar ^a   Ahmad, Farhan J ^a  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Curcumin nanoparticle; Pharmacokinetics; Q TOF MS MS; SAS process; Solubility; Tween 80; UPLC

Indexed keywords

ACETONE; ACETONITRILE; CURCUMIN; METHANOL; NANOPARTICLE; POLYSORBATE 80; SALBUTAMOL; SOLVENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; FLOW RATE; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; RAT; SCANNING ELECTRON MICROSCOPY; SOLID STATE; SOLUBILITY; SOLVENT EFFECT; SURFACE AREA; THERMAL ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WETTABILITY; X RAY DIFFRACTION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DEVICES; EQUIPMENT DESIGN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PROCEDURES; SURFACE PROPERTY; TANDEM MASS SPECTROMETRY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; EQUIPMENT DESIGN; MALE; NANOPARTICLES; PARTICLE SIZE; RATS, WISTAR; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84938843820     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.07.021     Document Type: Article

References (38)

1. D. Li, B. Lu, Z. Huang, P. Xu, H. Zheng, Y. Yin, H. Xu, X. Liu, L. Chen, and Y. Lou A novel melphalan polymeric prodrug: preparation and property study Carbohydr. Polym. 111 2014 928 935
2. M. Anwar, M.H. Warsi, N. Mallick, S. Akhter, S. Gahoi, G.K. Jain, S. Talegaonkar, F.J. Ahmad, and R.K. Khar Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats Eur. J. Pharm. Sci. 44 2011 241 249
3. N. Shan, and M.J. Zaworotko The role of cocrystals in pharmaceutical science Drug Discov. Today 13 2008 440 446
4. M.B. Hickey, M.L. Peterson, L.A. Scoppettuolo, S.L. Morrisette, A. Vetter, H. Guzmán, J.F. Remenar, Z. Zhang, M.D. Tawa, and S. Haley Performance comparison of a co-crystal of carbamazepine with marketed product Eur. J. Pharm. Biopharm. 67 2007 112 119
5. S.W. Jang, and M.J. Kang Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique Int. J. Pharm. 473 2014 187 193
6. A.L. Sarode, S.A. Malekar, C. Cote, and D.R. Worthen Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine Carbohydr. Polym. 112 2014 512 519
7. S. Sinha, M. Ali, S. Baboota, A. Ahuja, A. Kumar, and J. Ali Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir AAPS PharmSciTech 11 2010 518 527
8. H.R. Guzman, M. Tawa, Z. Zhang, P. Ratanabanangkoon, P. Shaw, C.R. Gardner, H. Chen, J.P. Moreau, Ö. Almarsson, and J.F. Remenar Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations J. Pharm. Sci. 96 2007 2686 2702
9. S. Li, S. Wong, S. Sethia, H. Almoazen, Y.M. Joshi, and A.T. Serajuddin Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH Pharm. Res. 22 2005 628 635
10. M.E. Brewster, and T. Loftsson Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 2007 645 666
11. C. Muankaew, P. Jansook, E. Stefánsson, and T. Loftsson Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients Int. J. Pharm. 474 2014 80 90
12. M. Mosharraf, and C. Nyström The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs Int. J. Pharm. 122 1995 35 47
13. M. Vogt, K. Kunath, and J.B. Dressman Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations Eur. J. Pharm. Biopharm. 68 2008 283 288
14. M.G. Fakes, B.J. Vakkalagadda, F. Qian, S. Desikan, R.B. Gandhi, C. Lai, A. Hsieh, M.K. Franchini, H. Toale, and J. Brown Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches Int. J. Pharm. 370 2009 167 174
15. T.T.-D. Tran, P.H.-L. Tran, M.N.U. Nguyen, K.T.M. Tran, M.N. Pham, P.C. Tran, and T. Van Vo Amorphous isradipine nanosuspension by the sonoprecipitation method Int. J. Pharm. 474 2014 146 150
16. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398
17. S. Setthacheewakul, S. Mahattanadul, N. Phadoongsombut, W. Pichayakorn, and R. Wiwattanapatapee Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats Eur. J. Pharm. Biopharm. 76 2010 475 485
18. R.K. Basniwal, H.S. Buttar, V. Jain, and N. Jain Curcumin nanoparticles: preparation, characterization, and antimicrobial study J. Agric. Food Chem. 59 2011 2056 2061
19. D. Sun, X. Zhuang, X. Xiang, Y. Liu, S. Zhang, C. Liu, S. Barnes, W. Grizzle, D. Miller, and H.-G. Zhang A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes Mol. Ther. 18 2010 1606 1614
20. B. Wahlang, Y.B. Pawar, and A.K. Bansal Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model Eur. J. Pharm. Biopharm. 77 2011 275 282
21. Y.-M. Tsai, C.-F. Chien, L.-C. Lin, and T.-H. Tsai Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration Int. J. Pharm. 416 2011 331 338
22. O. Naksuriya, S. Okonogi, R.M. Schiffelers, and W.E. Hennink Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment Biomaterials 35 2014 3365 3383
23. M.-S. Kim, S.-J. Jin, J.-S. Kim, H.J. Park, H.-S. Song, R.H. Neubert, and S.-J. Hwang Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process Eur. J. Pharm. Biopharm. 69 2008 454 465
24. J.-S. Kim, M.-S. Kim, H.J. Park, S.-J. Jin, S. Lee, and S.-J. Hwang Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process Int. J. Pharm. 359 2008 211 219
25. H.J. Park, M.-S. Kim, S. Lee, J.-S. Kim, J.-S. Woo, J.-S. Park, and S.-J. Hwang Recrystallization of fluconazole using the supercritical antisolvent (SAS) process Int. J. Pharm. 328 2007 152 160
26. Y.-M. Chen, M. Tang, and Y.-P. Chen Recrystallization and micronization of sulfathiazole by applying the supercritical antisolvent technology Chem. Eng. J. 165 2010 358 364
27. L. Zhiyi, J. Jingzhi, L. Xuewu, T. Huihua, and W. Wei Experimental investigation on the micronization of aqueous cefadroxil by supercritical fluid technology J. Supercrit. Fluids 48 2009 247 252
28. M.-S. Kim, S. Lee, J.-S. Park, J.-S. Woo, and S.-J. Hwang Micronization of cilostazol using supercritical antisolvent (SAS) process: effect of process parameters Powder Technol. 177 2007 64 70
29. T. Cardoso, V. Geraldes, J. Cabral, and A. Palavra Characterization of minocycline powder micronized by a supercritical antisolvent (SAS) process J. Supercrit. Fluids 46 2008 71 76
30. N. Mezzomo, S.R. Ferreira, Supercritical anti-solvent precipitation of sodium ibuprofen, in: Proceedings of III Iberoamerican Conference on Supercritical Fluids, Applied Thermodynamics and Supercritical Fluids Group, School of Chemical Engineering, Universidad del Valle Cali, 2013.
31. T. Yang, F.-D. Cui, M.-K. Choi, J.-W. Cho, S.-J. Chung, C.-K. Shim, and D.-D. Kim Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation Int. J. Pharm. 338 2007 317 326
32. Y. Javadzadeh, M. Siahi-Shadbad, M. Barzegar-Jalali, and A. Nokhodchi Enhancement of dissolution rate of piroxicam using liquisolid compacts Farmaco 60 2005 361 365
33. N. Ahmad, M.H. Warsi, Z. Iqbal, M. Samim, and F.J. Ahmad Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles Drug Test. Anal. 6 2014 257 267
34. M. Anwar, M. Asfer, A.P. Prajapati, S. Mohapatra, S. Akhter, A. Ali, and F.J. Ahmad Synthesis and in vitro localization study of curcumin-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system Int. J. Pharm. 468 2014 158 164
35. E. Reverchon, G. Della Porta, I. De Rosa, P. Subra, and D. Letourneur Supercritical antisolvent micronization of some biopolymers J. Supercrit. Fluids 18 2000 239 245
36. O. Suwantong, P. Opanasopit, U. Ruktanonchai, and P. Supaphol Electrospun cellulose acetate fiber mats containing curcumin and release characteristic of the herbal substance Polymer 48 2007 7546 7557
37. H. Zhang, M. Yao, R.A. Morrison, and S. Chong Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats Arch. Pharmacal Res. 26 2003 768 772
38. V.H. Lee, A. Yamamoto, and U.B. Kompella Mucosal penetration enhancers for facilitation of peptide and protein drug absorption Crit. Rev. Ther. Drug Carrier Syst. 8 1991 91 192